Bnp Paribas Asset Management Holding S.A. Amphastar Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 199 shares of AMPH stock, worth $4,907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
199Holding current value
$4,907% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMPH
# of Institutions
261Shares Held
32.9MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$147 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$66.3 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$50.2 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$40.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$38.9 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.21B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...